Resultado de búsqueda
7 de may. de 2024 · One of the world’s largest efforts to find effective COVID-19 treatments will evaluate the impact of REGN-COV2 on mortality, hospital stays, and the need for ventilation. RECOVERY COVID-19 phase 3 trial to evaluate Regeneron’s REGN-COV2 antibody cocktail | University of Oxford
- Comparison of five tests used to ... - University of Oxford
Research Health Coronavirus. New research shows that, in a...
- News | University of Oxford
Nine Oxford scientists elected as Royal Society Fellows....
- Comparison of five tests used to ... - University of Oxford
Hace 5 días · Research Health Coronavirus. New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results.
Hace 5 días · Nine Oxford scientists elected as Royal Society Fellows. Awards. Mathematical, Physical and Life Sciences. Medical Sciences. University. 16 May 2024.
Hace 5 días · Babies and the most vulnerable are at risk of death if vaccination rates for whooping cough don't increase, according to experts at the University of Oxford. Five babies have died from the virus in the first quarter of 2024 as cases continue to rise in England.
Hace 5 días · Do not use an Oxford Academic personal account. Following successful sign in, you will be returned to Oxford Academic. If you do not have a society account or have forgotten your username or password, please contact your society. Sign in using a personal account. Some societies use Oxford Academic personal accounts to provide access to their ...
Hace 5 días · COVID-19 outbreak. Coronavirus disease 2019 (COVID-19) is the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) A pneumonia of unknown cause detected in ...
Hace 14 horas · It created one of the first vaccines against the disease in partnership with the University of Oxford. The drug, called Vaxzevria, will be withdrawn from the market, it announced recently, amid falling demand and the development of new vaccines designed to fight specific Covid-19 variants.
